Simbolo, Michele
Centonze, Giovanni
Gkountakos, Anastasios
Monti, Valentina
Maisonneuve, Patrick
Golovco, Stela
Sabella, Giovanna
Del Gobbo, Alessandro
Gobbo, Stefano
Ferrero, Stefano
Fabbri, Alessandra
Pardo, Carlotta
Garzone, Giovanna
Prinzi, Natalie
Pusceddu, Sara
Testi, Adele
Rolli, Luigi
Mangogna, Alessandro
Bercich, Luisa
Benvenuti, Mauro Roberto
Bria, Emilio
Pilotto, Sara
Berruti, Alfredo
Pastorino, Ugo
Capella, Carlo
Infante, Maurizio
Milella, Michele
Scarpa, Aldo http://orcid.org/0000-0003-1678-739X
Milione, Massimo
Funding for this research was provided by:
Ministero della Salute (ERP-2017-23671129)
Fondazione AIRC per la ricerca sul cancro ETS (Integrative molecular analysis of pure, combined lung large cell neuroendocrine carcinoma (LCNEC), 26343)
Article History
Received: 8 June 2023
Revised: 13 November 2023
Accepted: 5 December 2023
First Online: 3 January 2024
Declarations
:
: Ethics Committee Approval (ECA) was obtained at ARC-Net Research Centre-Verona, ECA no. 2173-prot.26775 (June 1, 2012) and Fondazione IRCCS Istituto Nazionale Tumori-Milan ECA n. INT 171/16 (November 16, 2016). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki. Results presented in this article contain no personally identifiable information from the study.
: Dr. Pilotto reports personal fees from Astra-Zeneca, Eli-Lilly, AMGEN, BMS, Boehringer Ingelheim, Merck & Co. and Rochen and grants from Astra-Zeneca, BMS, outside the submitted work. Dr. Bria reports personal fees; non-financial support and other from MSD, Astra-Zeneca, Pfizer, Eli-Lilly, BMS, Novartis and Roche; and grants from Astra-Zeneca, Roche, outside the submitted work. Dr. Milella reports personal fees from Pfizer, personal fees from MSD, personal fees from AstraZeneca, grants from Roche, personal fees from EUSA Pharma, personal fees from Boehringer Ingelheim, personal fees from Ipsen, and grants from BMS, outside the submitted work. Dr. Scarpa reports personal fees from Astra-Zeneca, AMGEN, Incyte Biosciences, Tesaro-GSK, and MSD, outside the submitted work. All other authors have nothing to disclose.